Calidi Biotherapeutics Inc. (NYSE American: CLDI) Sees Growth, Potential in Oncology Drug Development, a Critical Frontier in Cancer Treatment
According to the American Cancer Society, cancer is the second leading cause of death globally. Oncology drugs are a cornerstone…